Cav3.2 calcium channels: The key protagonist in the supraspinal effect of paracetamol

Pain

Volumn 155, Issue 4, 2014, Pages 764-772

  Kerckhove, Nicolas ^a,b   Mallet, Christophe ^a,b   François, Amaury ^d,e   Boudes, Mathieu ^f   Chemin, Jean ^d,e   Voets, Thomas ^f   Bourinet, Emmanuel ^d,e   Alloui, Abdelkrim ^a,b   Eschalier, Alain ^a,b,c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b Neuro Dol ^*  (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^e UNIV MONTPELLIER   (France)

^f LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

Analgesia; Paracetamol; TRPV1

Indexed keywords

CAPSAICIN; FATTY ACID AMIDASE; MORPHINE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PARACETAMOL; VANILLOID RECEPTOR 1; VOLTAGE GATED CALCIUM CHANNEL;

ACTIMETRY; ADULT; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; FEMALE; FORMALIN TEST; HUMAN; HUMAN CELL; HYPERALGESIA; INFLAMMATORY PAIN; LOCOMOTION; MALE; MONARTHRITIS; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; TAIL IMMERSION TEST; VON FREY TEST;

ANALGESIA; CA(V)3.2 CHANNEL; PARACETAMOL; TRPV1;

4-AMINOPYRIDINE; ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; ARTHRITIS; CALCIUM CHANNELS, T-TYPE; CELLS, CULTURED; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; GANGLIA, SPINAL; HUMANS; MALE; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; MORPHINE; NEURONS; PAIN MEASUREMENT; POTASSIUM CHANNEL BLOCKERS; SPINAL CORD; TETRAETHYLAMMONIUM; TRPV CATION CHANNELS;

EID: 84896404236     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.01.015     Document Type: Article

References (56)

1. A. Alloui, C. Chassaing, J. Schmidt, D. Ardid, C. Dubray, A. Cloarec, and A. Eschalier Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats Eur J Pharmacol 443 2002 71 77
2. D. Andersson, C. Gentry, L. Alenmyr, D. Killander, S. Lewis, A. Andersson, B. Bucher, J.-L. Galzi, O. Sterner, S. Bevan, E. Högestätt, and P. Zygmunt TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ(9)-tetrahydrocannabiorcol Nat Commun 2 2011 551
3. G. Barbara, A. Alloui, J. Nargeot, P. Lory, A. Eschalier, E. Bourinet, and J. Chemin T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids J Neurosci 29 2009 13106 13114
4. D.A. Barrière, C. Mallet, A. Blomgren, C. Simonsen, L. Daulhac, F. Libert, E. Chapuy, M. Etienne, E.D. Högestätt, P.M. Zygmunt, and A. Eschalier Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain PLoS One 8 2013 e70690
5. A.J. Becker, J. Pitsch, D. Sochivko, T. Opitz, M. Staniek, C.-C. Chen, K.P. Campbell, S. Schoch, Y. Yaari, and H. Beck Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy J Neurosci 28 2008 13341 13353
6. M. Beltramo, N. Stella, A. Calignano, S.Y. Lin, A. Makriyannis, and D. Piomelli Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 1997 1094 1097
7. J. Bonnefont, A. Alloui, E. Chapuy, E. Clottes, and A. Eschalier Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism Anesthesiology 99 2003 976 981
8. E. Bourinet, A. Alloui, A. Monteil, C. Barrère, B. Couette, O. Poirot, A. Pages, J. McRory, T.P. Snutch, A. Eschalier, and J. Nargeot Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception EMBO J 24 2005 315 324
9. B. Buisson, L. Laflamme, S.P. Bottari, M. de Gasparo, N. Gallo-Payet, and M.D. Payet A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells J Biol Chem 270 1995 1670 1674
10. S. Butler, F. Godefroy, J. Besson, and J. Weil-Fugazza A limited arthritic model for chronic pain studies in the rat PAIN® 48 1992 73 81
11. M. Caterina, A. Leffler, A. Malmberg, W. Martin, J. Trafton, K. Petersen-Zeitz, M. Koltzenburg, A. Basbaum, and D. Julius Impaired nociception and pain sensation in mice lacking the capsaicin receptor Science 288 2000 306 319
12. J. Chemin, J. Nargeot, and P. Lory Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels J Biol Chem 282 2007 2314 2323
13. 2+ channels Science 302 2003 1416 1418
14. 2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain J Neurosci 30 2010 10360 10368
15. S. Choi, H.S. Na, J. Kim, J. Lee, S. Lee, D. Kim, J. Park, C.-C. Chen, K.P. Campbell, and H.-S. Shin Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels Genes Brain Behav 6 2007 425 431
16. V. Comunanza, E. Carbone, A. Marcantoni, E. Sher, and D. Ursu Calcium-dependent inhibition of T-type calcium channels by TRPV1 activation in rat sensory neurons Pflugers Arch 462 2011 709 722
17. J. Courade, C. Chassaing, L. Bardin, A. Alloui, and A. Eschalier 5-HT receptor subtypes involved in the spinal antinociceptive effect of acetaminophen in rats Eur J Pharmacol 432 2001 1 7
18. B. Crawley, O. Saito, S. Malkmus, B. Fitzsimmons, X.-Y. Hua, and T. Yaksh Acetaminophen prevents hyperalgesia in central pain cascade Neurosci Lett 442 2008 50 53
19. M. Dani, J. Guindon, C. Lambert, and P. Beaulieu The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors Eur J Pharmacol 573 2007 214 215
20. S.J. Danthi, J.A. Enyeart, and J.J. Enyeart Modulation of native T-type calcium channels by omega-3 fatty acids Biochem Biophys Res Commun 327 2005 485 493
21. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
22. I. Dittert, J. Benedikt, L. Vyklický, K. Zimmermann, P.W. Reeh, and V. Vlachová Improved superfusion technique for rapid cooling or heating of cultured cells under patch-clamp conditions J Neurosci Methods 151 2006 178 185
23. 7 receptors Eur J Pharmacol 677 2012 93 101
24. A. Francois, N. Kerckhove, M. Meleine, A. Alloui, C. Barrere, A. Gelot, V.N. Uebele, J.J. Renger, A. Eschalier, D. Ardid, and E. Bourinet State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects PAIN® 154 2013 283 293
25. E.D. Högestätt, B.A.G. Jönsson, A. Ermund, D.A. Andersson, H. Björk, J.P. Alexander, B.F. Cravatt, A.I. Basbaum, and P.M. Zygmunt Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system J Biol Chem 280 2005 31405 31412
26. S.M. Huang, T. Bisogno, T.J. Petros, S.Y. Chang, P.A. Zavitsanos, R.E. Zipkin, R. Sivakumar, A. Coop, D.Y. Maeda, L. De Petrocellis, S. Burstein, V. Di Marzo, and J.M. Walker Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain J Biol Chem 276 2001 42639 42644
27. 2+ channel activity by protein tyrosine phosphorylation J Microbiol Biotechnol 18 2008 365 368
28. M. Iftinca, J. Hamid, L. Chen, D. Varela, R. Tadayonnejad, C. Altier, R.W. Turner, and G.W. Zamponi Regulation of T-type calcium channels by Rho-associated kinase Nat Neurosci 10 2007 854 860
29. F. Kawai, T. Kurahashi, and A. Kaneko Adrenaline enhances odorant contrast by modulating signal encoding in olfactory receptor cells Nat Neurosci 2 1999 133 138
30. D. Kim, I. Song, S. Keum, T. Lee, M.J. Jeong, S.S. Kim, M.W. McEnery, and H.S. Shin Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels Neuron 31 2001 35 45
31. J. Lee, D. Kim, and H.-S. Shin Lack of delta waves and sleep disturbances during non-rapid eye movement sleep in mice lacking alpha1G-subunit of T-type calcium channels Proc Natl Acad Sci U S A 101 2004 18195 18199
32. J. Liu, A.R. Reid, and J. Sawynok Antinociception by systemically- administered acetaminophen (paracetamol) involves spinal serotonin 5-HT(7) and adenosine A(1) receptors, as well as peripheral adenosine A(1) receptors Neurosci Lett 536 2013 64 68
33. Y. Maeda, Y. Aoki, F. Sekiguchi, M. Matsunami, T. Takahashi, H. Nishikawa, and A. Kawabata Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels PAIN® 142 2009 127 132
34. C. Mallet, D.A. Barrière, A. Ermund, B.A.G. Jönsson, A. Eschalier, P.M. Zygmunt, and E.D. Högestätt TRPV1 in brain is involved in acetaminophen-induced antinociception PLoS One 5 2010 e12748
35. C. Mallet, L. Daulhac, J. Bonnefont, C. Ledent, M. Etienne, E. Chapuy, F. Libert, and A. Eschalier Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia PAIN® 139 2008 190 200
36. U.J. Moore, R.A. Seymour, and M.D. Rawlins The efficacy of locally applied aspirin and acetaminophen in postoperative pain after third molar surgery Clin Pharmacol Ther 52 1992 292 296
37. M.C. Nowycky, A.P. Fox, and R.W. Tsien Three types of neuronal calcium channel with different calcium agonist sensitivity Nature 316 1985 440 443
38. K. Okubo, M. Matsumura, Y. Kawaishi, Y. Aoki, M. Matsunami, Y. Okawa, F. Sekiguchi, and A. Kawabata Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice Br J Pharmacol 166 2012 1738 1743
39. K. Okubo, T. Takahashi, F. Sekiguchi, D. Kanaoka, M. Matsunami, T. Ohkubo, J. Yamazaki, N. Fukushima, S. Yoshida, and A. Kawabata Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats Neuroscience 188 2011 148 156
40. E. Palazzo, F. Rossi, and S. Maione Role of TRPV1 receptors in descending modulation of pain Mol Cell Endocrinol 286 2008 S79 S83
41. T. Pelissier, A. Alloui, F. Caussade, C. Dubray, A. Cloarec, J. Lavarenne, and A. Eschalier Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence J Pharmacol Exp Ther 278 1996 8 14
42. E. Perez-Reyes Molecular physiology of low-voltage-activated T-type calcium channels Physiol Rev 83 2003 117 161
43. 2+ signalling Cell Calcium 45 2009 611 624
44. G. Pickering, V. Estève, M.-A. Loriot, A. Eschalier, and C. Dubray Acetaminophen reinforces descending inhibitory pain pathways Clin Pharmacol Ther 84 2008 47 51
45. G. Pickering, M.-A. Loriot, F. Libert, A. Eschalier, P. Beaune, and C. Dubray Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism Clin Pharmacol Ther 79 2006 371 378
46. T.S. Reger, Z.-Q. Yang, K.-A.S. Schlegel, Y. Shu, C. Mattern, R. Cube, K.E. Rittle, G.B. McGaughey, G.D. Hartman, C. Tang, J. Ballard, Y. Kuo, T. Prueksaritanont, C.E. Nuss, S.M. Doran, S.V. Fox, S.L. Garson, Y. Li, R.L. Kraus, V.N. Uebele, J.J. Renger, and J.C. Barrow Pyridyl amides as potent inhibitors of T-type calcium channels Bioorg Med Chem Lett 21 2011 1692 1696
47. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 778
48. T. Takahashi, Y. Aoki, K. Okubo, Y. Maeda, F. Sekiguchi, K. Mitani, H. Nishikawa, and A. Kawabata Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain PAIN® 150 2010 183 191
49. 2+ channel alpha1G J Gen Physiol 124 2004 225 238
50. E.M. Talley, L.L. Cribbs, J.H. Lee, A. Daud, E. Perez-Reyes, and D.A. Bayliss Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels J Neurosci 19 1999 1895 1911
51. S. Todorovic, V. Jevtovic-Todorovic, S. Mennerick, E. Perez-Reyes, and C. Zorumski Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide Mol Pharmacol 60 2001 603 610
52. V. Uebele, A. Gotter, C. Nuss, R. Kraus, S. Doran, S. Garson, D. Reiss, Y. Li, J. Barrow, T. Reger, Z.-Q. Yang, J. Ballard, C. Tang, J. Metzger, S.-P. Wang, K. Koblan, and J. Renger Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice J Clin Invest 119 2009 1659 1667
53. 2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice Cell Calcium 49 2011 12 22
54. L. Zhang, Y. Zhang, D. Jiang, P.F. Reid, X. Jiang, Z. Qin, and J. Tao Alpha-cobratoxin inhibits T-type calcium currents through muscarinic M4 receptor and Gο-protein βγ subunits-dependent protein kinase A pathway in dorsal root ganglion neurons Neuropharmacology 62 2012 1062 1072
55. Y. Zhang, X. Jiang, T.P. Snutch, and J. Tao Modulation of low-voltage-activated T-type Ca(2+) channels Biochim Biophys Acta 1828 2013 1550 1559
56. P.M. Zygmunt, H. Chuang, P. Movahed, D. Julius, and E.D. Högestätt The anandamide transport inhibitor AM404 activates vanilloid receptors Eur J Pharmacol 396 2000 39 42